Trial to Evaluate an Optimization Procedure of Alveolar Recruitment During Transport Performed by Nurse Anesthetists in Intensive Care (ESCORTE)

May 30, 2024 updated by: University Hospital, Montpellier

Randomized Controlled Trial to Evaluate an Optimization Procedure of Alveolar Recruitment During Transport Performed by Nurse Anesthetists in Intensive Care

Intra hospital transport of ICU patients is still at high risk of respiratory complications.We propose to determine if endotracheal tube clamping prior to disconnect ventilator allows to avoid oxygenation decrease.

Study Overview

Status

Completed

Detailed Description

Changing respiratory support and multiples endotracheal tube disconnections may induce a loss of PEEP and finally lead to alveolar derecruitment. This study is an evaluation of a care procedure to limit the incidence of alveolar derecruitment in ventilated intubated ICU patients during transport for CT scan.

Intra hospital transport of ICU patients are performed by anesthesiologist nurses, the physician entrusts them this activity.

This is a randomized controlled study, the procedure is to clamp endotracheal tube before each disconnection from ventilator.

Study Type

Interventional

Enrollment (Actual)

250

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Montpellier, France, 34295
        • Departement d'anesthésie et réanimation Gui de Chauliac (DAR C)

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • intensive care patient
  • intubated, sedated, controlled assisted ventilation
  • Intra hospital transport for CT scan
  • arterial catheter
  • the patient or his trusted person consent to the study

Exclusion Criteria:

  • Patient Covid tests positive or Covid test results not received
  • extubated, unsedated,
  • reinforced tube
  • tracheotomy
  • pregnancy
  • guardianship

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control group
The transport will be released without a clamping of endotracheal tube before each disconnection from ventilator.
Experimental: Clamping group
The transport will be released with a clamping of endotracheal tube before each disconnection from ventilator.
The transport will be released in accordance with SFAR SRLF guideline. Before each disconnection from ventilator endotracheal tube will be clamped.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Measure of the pa02/Fi02
Time Frame: 1 hour after the end of the transport
Evaluate the effectiveness of a procedure to avoid alveolar delisting, measured by the absence of a decrease in the PaO2/FiO2 ratio (before transport and 1 hour after return to bed) during an HIT performed by a nurse anaesthetist/caregiver team, of intubated and ventilated resuscitation patients in a controlled assisted volume.
1 hour after the end of the transport

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Assessment of the pa02
Time Frame: 1 hour after the end of the HIT
Evaluate the impact of the procedure on the absence of PaO2 reduction (before transport and 1 hour after return to bed)
1 hour after the end of the HIT
Assessment of the pa02
Time Frame: immediately after the end of the HIT
Evaluate the effectiveness of the procedure on Pa02 immediately after reconnection to the heavy resuscitation ventilator
immediately after the end of the HIT
Assessment of the pa02
Time Frame: 6 hours after the end of of the HIT
Evaluate the effectiveness of the procedure on Pa02 immediately after reconnection to the heavy resuscitation ventilator
6 hours after the end of of the HIT
length of stay
Time Frame: up to 28 days
Evaluate the impact of the intervention on the length of ICU stay
up to 28 days
duration of invasive ventilation
Time Frame: up to 28 days
Evaluate the impact of the intervention on the invasive ventilation
up to 28 days
occurrence of adverse events during the HIT
Time Frame: immediately after the end of the HIT
occurrence of adverse events related to the clamping
immediately after the end of the HIT

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 17, 2020

Primary Completion (Actual)

December 18, 2023

Study Completion (Actual)

December 22, 2023

Study Registration Dates

First Submitted

November 6, 2019

First Submitted That Met QC Criteria

November 8, 2019

First Posted (Actual)

November 12, 2019

Study Record Updates

Last Update Posted (Actual)

May 31, 2024

Last Update Submitted That Met QC Criteria

May 30, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RECHMPL19_0070

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

12 months after the main publication

IPD Sharing Access Criteria

Data are provided to qualified investigators free of charge. Required documents to request data include a summary of the research plan, request form, and IRB review. Dataset will be shared after careful examination by the study board of investigators.

IPD Sharing Supporting Information Type

  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Respiratory Complication

Clinical Trials on Clamping of the ventilator endotracheal tube

Subscribe